Cost ramifications of increased reporting of detectable plasma HIV-1 RNA levels by the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 version 1.0 viral load test.
Willig
James H
JH
Nevin
Christa R
CR
Raper
James L
JL
Saag
Michael S
MS
Mugavero
Michael J
MJ
Willig
Amanda L
AL
Burkhardt
Jeffrey H
JH
Schumacher
Joseph E
JE
Johnson
Victoria A
VA
D000163:Acquired Immunodeficiency Syndrome / Q000097:blood* / Q000188:drug therapy / Q000191:economics*; D019380:Anti-HIV Agents / Q000627:therapeutic use; D044966:Anti-Retroviral Agents / Q000191:economics / Q000627:therapeutic use; D017281:Cost of Illness; D015497:HIV-1 / Q000235:genetics*; D006801:Humans; D012367:RNA, Viral / Q000097:blood*; D019562:Viral Load / Q000379:methods*; D014766:Viremia / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy
D019380:Anti-HIV Agents; D044966:Anti-Retroviral Agents; D012367:RNA, Viral